Veradermics, Incorporated (MANE) Presents at Leerink Global Healthcare Conference 2026 Transcript

Group 1 - The company is focused on addressing hair loss, which is identified as the most prevalent chronic dermatologic condition, affecting approximately 80 million people [2] - The development of a Minoxidil extended-release tablet is driven by the recognition of the drug's potential beyond its original use as a blood pressure medication, particularly through off-label applications [3]